Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enfuvirtide for Initial Phase of Antiretroviral Therapy in HIV-infected Patients
NCT00302822Phase 3Completed
- Sponsor
- ANRS
- Start
- Apr 2006
- Primary completion
- Dec 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enfuvirtide in human immunodeficiency virus infection (HIV), acquired immunodeficiency syndrome (AIDS), sponsored by ANRS. Started Apr 2006; status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on NCT00302822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00302822.